Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
AMP-activated protein kinase-dependent and -independent mechanisms underlying in vitro antiglioma action of compound C
Neurochemical research , 35 (10), 1575-1587
doi: 10.3389/fendo.2019.00450 89 SchamsDBerishaB
Zepbound (tirzepatide) is a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist that is FDA-approved along with increased physical activity and a reduced-calorie diet for chronic weight management in adults with a starting body mass index (BMI) of: 30 kg/m^2 or higher (obesity) or 27 kg/m^2 or higher (overweight) with at least one weight-related condition such as high cholesterol, high blood pressure (hypertension), type 2 diabetes, heart disease, or obstructive sleep apnea
Every batch undergoes rigorous HPLC purity analysis and Mass Spectrometry identity confirmation under Good Laboratory Practice (GLP) standards to ensure 99%+ purity and research reproducibility
Ditzenberger GL, Lake JE, Kitch DW, et al
US$ 27.64
US$ 29.48
US$ 28.51
US$ 27.96
US$ 25.69
US$ 25.71
US$ 28.67
US$ 26.82
US$ 28.54
US$ 24.68
